Blemish Spot Treatment — Class II drug recall D-0487-2026
Ongoing recall by Island Kinetics, Inc. d.b.a. CoValence Laboratories, reported 2026-04-22, distributed nationwide. Failed Stability Specifications
| Recall number | D-0487-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Island Kinetics, Inc. d.b.a. CoValence Laboratories, Chandler, AZ, United States |
| Recall initiated | 2026-04-01 |
| Classified | 2026-04-22 |
| Reported by FDA | 2026-04-22 |
| Distributed | Nationwide (US) |
| Quantity | 28,163 bottles |
| Reason classes | specification failure |
| UPC / GTIN / UDI-DI | 00610563138739 |
| Lot numbers | 4228D2, 4229D1, 5147D2 |
| Expiration dates | 2026-07-31, 2027-04-30 |
Product
Blemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz (15 ml) bottles, Skin Script, Chandler, AZ 85226, UPC 6 10563 13873 9.
Reason for recall
Failed Stability Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0487-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.